- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/06 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ringAlkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
Patent holdings for IPC class C07D 217/06
Total number of patents in this class: 252
10-year publication summary
|
17
|
15
|
19
|
21
|
24
|
18
|
17
|
21
|
13
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Opna Bio SA | 34 |
10 |
| Neophore Limited | 15 |
8 |
| Boehringer Ingelheim International GmbH | 4482 |
7 |
| Mitsubishi Tanabe Pharma Corporation | 386 |
5 |
| Bristol-myers Squibb Company | 4758 |
4 |
| Conopco, Inc. | 5161 |
4 |
| Astellas Pharma Inc. | 1043 |
4 |
| Chugai Seiyaku Kabushiki Kaisha | 1438 |
4 |
| Jiangsu Hengrui Medicine Co., Ltd. | 688 |
4 |
| Minerva Neurosciences, Inc. | 58 |
4 |
| Respiratorius AB | 9 |
4 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 738 |
4 |
| UDC Ireland Limited | 505 |
4 |
| Shenzhen Cell Inspire Pharmaceutical Development Co., Ltd. | 8 |
4 |
| Board of Regents, The University of Texas System | 6231 |
3 |
| Kaneka Corporation | 4848 |
3 |
| Takeda Pharmaceutical Company Limited | 2695 |
3 |
| Daiichi Sankyo Company, Limited | 1892 |
3 |
| Merial, Inc. | 208 |
3 |
| Newron Pharmaceuticals S.p.A. | 57 |
3 |
| Other owners | 164 |